View:
COMPANY DATA:
COMPANY CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP.
CENTRAL INDEX KEY: 0001447028
SIC: 2834
IRS NUMBER: 98-0597776
STATE OF INCORPORATION: FOREIGN
FISCAL YEAR END: 12/31
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 131030431
BUSINESS ADDRESS:
STREET 1: 100-8900 Glenlyon Parkway
CITY/PROVIINCE: Burnaby, British Columbia
COUNTRY: Canada
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3201
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Newby, Steven T
CENTRAL INDEX KEY: 0000905383
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
BUSINESS PHONE: 3019906364
MAIL ADDRESS:
STREET 1: 12716 Split Creek Court
CITY: North Potomac
STATE: MD
ZIP: 20878
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
TEKMIRA PHARMACEUTICALS CORPORATION
(Name of Issuer)
Common Stock, no par value
(Title of Class of Securities)
87911B209
(CUSIP Number)
August 6th, 2013
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Scheduleis filed:
[ ]Rule 13d-1(b)
[ x ]Rule 13d-1(c)
[ ]Rule 13d-1(d)
CUSIP No. 87911B209....................
1.Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
.......................................................................
STEVEN T NEWBY
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)....................................................................
(b)....................................................................
3.SEC Use Only
.......................................................................
4.Citizenship or Place of Organization
.......................................................................
United States of America
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5.Sole Voting Power
.......................................................................
944,000 Shares
6.Shared Voting Power
.......................................................................
7.Sole Dispositive
Power..................................................................
944,000 Shares
8.Shared Dispositive Power
.......................................................................
9.Aggregate Amount Beneficially Owned by Each Reporting
Person.................................................................
944,000 Shares
10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions).................................
11.Percent of Class Represented by Amount in Row (9)
.......................................................................
6.54%*
12.Type of Reporting Person (See Instructions)
.......................................................................
INDIVIDUAL
.......................................................................
* Percentage based on 14,423,401 shares of Issuer's common
stock, no par value, as reported on Tekmira Pharmaceutical
Corporations Form 6-K, filed with SEC on August 12th, 2013
.......................................................................
Item 1(a)Name of Issuer
TEKMIRA PHARMACEUTICALS CORPORATION
Item 1(b)Address of Issuer's Principal Executive Offices
100-8900 Glenlyon Parkway Burnaby, British Columbia
Canada V5J 5J8
Item 2(a)Name of Person Filing
Steven T Newby
Item 2(b)Address of Principal Business Office or, if none, Residence
12716 Split Creek Court, North Potomac, MD, 20878
Item 2(c)Citizenship
United States of America
Item 2(d)Title of Class of Securities
Common Stock, no Par Value
Item 2(e)CUSIP Number
87911B209
Item 3.If this statement is filed pursuant to 13d-1(b) or
13d-2(b) or (c), check whether the person filing is a:
(a)[ ]Broker or dealer registered under section 15 of the Act
(15 U.S.C.78o).
(b)[ ]Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)[ ]Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d)[ ]Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C 80a-8).
(e)[ ]An investment adviser in accordance with 13d-1(b)(1)(ii)(E);
(f)[ ]An employee benefit plan or endowment fund in accordance with
13d-1(b)(1)(ii)(F);
(g)[ ]A parent holding company or control person in accordance with
13d-1(b)(1)(ii)(G);
(h)[ ]A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i)[ ]A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of
the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)[ ]Group, in accordance with 13d-1(b)(1)(ii)(J).
Item 4.Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a)Amount beneficially owned: __944,000___.
(b)Percent of class: ______6.54%_______________
(c)Number of shares as to which the person has:
(i)Sole power to vote or to direct the vote __944,000___.
(ii)Shared power to vote or to direct the vote _____________.
(iii)Sole power to dispose or to direct the disposition of
___944,000___.
(iv)Shared power to dispose or to direct the disposition of
_______________.
Item 5.Ownership of Five Percent or Less of a Class
Not applicable
Item 6.Ownership of More than Five Percent Of A Class.
If this statement is being filed to report the fact that
as of the date hereof the reporting person has become
the beneficial owner of more than five percent
of the class of securities, check the following [ X ].
Item 7.Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company
or Control Person.
Not applicable.
Item 8.Identification and Classification of Members of the Group
Not applicable
Item 9.Notice of Dissolution of Group
Not applicable.
Item 10.Certification
By signing below I certify that, to the best of my knowledge and
belief,the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.
________________________________
Date August 16th, 2013
________________________________
Signature /s/ Steven T Newby